Health
Mefloquine shows potential as anti-SARS-CoV-2 drug – News-Medical.Net
A team of scientists from Japan has identified the approved anti-material drug, mefloquine, as a potential candidate to treat severe acute respiratory syndrome…
A team of scientists from Japan has identified the approved anti-material drug, mefloquine, as a potential candidate to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Specifically, mefloquine has been shown to prevent the entry of SARS-CoV-2 into host cells and reduce the viral loadin vitro. The study is currently available on the bioRxiv* preprint server.
The recent pandemic of coronavirus disease 2019 (COVID-19) has put a substantial amount of burden on healthcare…
-
Noosa News23 hours agoBrisbane flights cancelled as severe weather set to lash coast
-
Noosa News20 hours agoFormer Brisbane Lions sponsor goes bust, leaving 200 workers in limbo
-
Noosa News19 hours agoHero rescuer reveals terrifying details of horror shark attack at Cabarita Beach in NSW
-
Noosa News22 hours agoUpstate Palm Beach Is Launching Its Debut Queensland Pilates Studio with Free Reformer Classes All Opening Weekend Long